Cervical Disc Degenerative Disorder
4
0
1
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
5 treatments under study, led by Cellentra Vcbm
Research Leaders
5 sponsors active, led by MT Ortho s.r.l.
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 4 trials
100.0%
+13.4% vs benchmark
0%
0 trials in Phase 3/4
33%
1 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 3 completed trials
Clinical Trials (4)
Post-market Observational Clinical Study With the CE-marked Implantable Class IIb Medical Device "ITC CERVICAL"
Evaluating The Safety and Effectiveness of The NeoDisc™ Versus ACDF in Subjects With Single-Level Cervical Disc Disease
M6-C Artificial Cervical Disc Two-Level IDE Pivotal Study
Cellentra Viable Cell Bone Matrix (VCBM) Anterior Cervical Discectomy and Fusion Outcomes Study (VCBM/MaxAn)
Research Network
Common Treatments
- Cellentra Vcbm1
- Neodisc1
- Acdf1
- M6c Artificial Cervical Disc1
- Instrumented Anterior Cervical Discectomy And Fusion Acdf1
Active Sponsors
- MT Ortho s.r.l.1
- Orthofix Inc.1
- NuVasive1
- Spinal Kinetics1
- Zimmer Biomet1
Top Investigators
Medical Monitor
Orthofix Inc.
Biomet Spine
Related Conditions
- Cervical Fusion1